United States · FDA National Drug Code directory
Kanka Triple Action
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10157-2127_225703ba-c471-4c9a-9c01-4b7f075b7878
- Product NDC
- 10157-2127
- Form
- GEL
- Composition / generic term
- BENZOCAINE and MENTHOL, UNSPECIFIED FORM
- Labeler
- Blistex Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20250106
- Source listing expiry
- 20261231
Source-listed ingredients
- BENZOCAINE — 20 g/100g
- MENTHOL, UNSPECIFIED FORM — 2 g/100g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (10157-2127-1) / 11.9 g in 1 TUBE · 10157-2127-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →